ID

39751

Beschreibung

Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002 AM1); ODM derived from: https://clinicaltrials.gov/show/NCT01532973

Link

https://clinicaltrials.gov/show/NCT01532973

Stichworte

Versionen (1)
  1. 16.02.20 16.02.20 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

16. Februar 2020

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hepatitis, Viral, Human NCT01532973

Englisch

Eligibility Hepatitis, Viral, Human NCT01532973

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
body mass index (bmi) of 18 to ≤ 37 kg/m^2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
clinical diagnosis of chronic hcv infection defined by positive serology for hcv for at least 6 months and detectable hcv rna in peripheral blood ≥105 iu/ml at screening
Beschreibung

Hepatitis C, Chronic | Serology positive HCV | Hepatitis C virus RNA assay Peripheral blood

Datentyp

boolean

Alias
UMLS CUI [1]
C0524910
UMLS CUI [2,1]
C0242089
UMLS CUI [2,2]
C0220847
UMLS CUI [3,1]
C1272251
UMLS CUI [3,2]
C0229664
participant must be infected with hcv gt1a, gt1b, or gt 3
Beschreibung

Hepatitis C Genotype

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019196
UMLS CUI [1,2]
C1533728
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
co-infection with gt1 and gt3
Beschreibung

Coinfection Genotype

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0275524
UMLS CUI [1,2]
C1533728
estimated creatinine clearance of ≤70 ml/min based on the cockcroft-gault equation
Beschreibung

Estimation of creatinine clearance by Cockcroft-Gault formula

Datentyp

boolean

Alias
UMLS CUI [1]
C2711451
history of stroke, chronic seizures, or major neurological disorder
Beschreibung

Cerebrovascular accident | Seizures chronic | Nervous system disorder Major

Datentyp

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2,1]
C0036572
UMLS CUI [2,2]
C0205191
UMLS CUI [3,1]
C0027765
UMLS CUI [3,2]
C0205164
history of clinically significant endocrine, gastrointestinal (excepting hcv infection), cardiovascular, hematological, immunological, renal, respiratory, or genitourinary abnormalities or diseases
Beschreibung

Endocrine System Diseases | Gastrointestinal Diseases | Exception Hepatitis C | Cardiovascular Diseases | Hematological Disease | Immune System Diseases | Kidney Diseases | Respiration Disorders | Disorder of the genitourinary system

Datentyp

boolean

Alias
UMLS CUI [1]
C0014130
UMLS CUI [2]
C0017178
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0019196
UMLS CUI [4]
C0007222
UMLS CUI [5]
C0018939
UMLS CUI [6]
C0021053
UMLS CUI [7]
C0022658
UMLS CUI [8]
C0035204
UMLS CUI [9]
C0080276
history of neoplastic disease
Beschreibung

Neoplastic disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1882062
positive hepatitis b surface antigen at the pre-study (screening) visit
Beschreibung

Hepatitis B surface antigen positive

Datentyp

boolean

Alias
UMLS CUI [1]
C0149709
has had major surgery, donated or lost 1 unit of blood (approximately 500 ml) or participated in another investigational study within 4 weeks prior to the prestudy (screening) visit.
Beschreibung

Major surgery | Blood Donation Amount | Blood Loss Amount | Study Subject Participation Status | Research study

Datentyp

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2,1]
C0005794
UMLS CUI [2,2]
C1265611
UMLS CUI [3,1]
C3163616
UMLS CUI [3,2]
C1265611
UMLS CUI [4]
C2348568
UMLS CUI [5]
C0681814
previous treatments (s) with nonstructural protein 5a (ns5a) inhibitors
Beschreibung

NS5A Inhibitor

Datentyp

boolean

Alias
UMLS CUI [1]
C3883357
<4 weeks since administration of any experimental protease inhibitor
Beschreibung

Protease Inhibitors Investigational Recent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0033607
UMLS CUI [1,2]
C1517586
UMLS CUI [1,3]
C0332185
previous exposure to interferon-alpha and/or ribavirin within 3 month prior to the first dose of elbasvir in the study
Beschreibung

Exposure to Interferon-alpha | Exposure to Ribavirin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0002199
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C0035525
clinical or laboratory evidence of advanced or decompensated liver disease
Beschreibung

Liver disease Advanced | Decompensated liver disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C4075847
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hepatitis, Viral, Human NCT01532973

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Body mass index
Item
body mass index (bmi) of 18 to ≤ 37 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Hepatitis C, Chronic | Serology positive HCV | Hepatitis C virus RNA assay Peripheral blood
Item
clinical diagnosis of chronic hcv infection defined by positive serology for hcv for at least 6 months and detectable hcv rna in peripheral blood ≥105 iu/ml at screening
boolean
C0524910 (UMLS CUI [1])
C0242089 (UMLS CUI [2,1])
C0220847 (UMLS CUI [2,2])
C1272251 (UMLS CUI [3,1])
C0229664 (UMLS CUI [3,2])
Hepatitis C Genotype
Item
participant must be infected with hcv gt1a, gt1b, or gt 3
boolean
C0019196 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Coinfection Genotype
Item
co-infection with gt1 and gt3
boolean
C0275524 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
estimated creatinine clearance of ≤70 ml/min based on the cockcroft-gault equation
boolean
C2711451 (UMLS CUI [1])
Cerebrovascular accident | Seizures chronic | Nervous system disorder Major
Item
history of stroke, chronic seizures, or major neurological disorder
boolean
C0038454 (UMLS CUI [1])
C0036572 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0027765 (UMLS CUI [3,1])
C0205164 (UMLS CUI [3,2])
Endocrine System Diseases | Gastrointestinal Diseases | Exception Hepatitis C | Cardiovascular Diseases | Hematological Disease | Immune System Diseases | Kidney Diseases | Respiration Disorders | Disorder of the genitourinary system
Item
history of clinically significant endocrine, gastrointestinal (excepting hcv infection), cardiovascular, hematological, immunological, renal, respiratory, or genitourinary abnormalities or diseases
boolean
C0014130 (UMLS CUI [1])
C0017178 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0019196 (UMLS CUI [3,2])
C0007222 (UMLS CUI [4])
C0018939 (UMLS CUI [5])
C0021053 (UMLS CUI [6])
C0022658 (UMLS CUI [7])
C0035204 (UMLS CUI [8])
C0080276 (UMLS CUI [9])
Neoplastic disease
Item
history of neoplastic disease
boolean
C1882062 (UMLS CUI [1])
Hepatitis B surface antigen positive
Item
positive hepatitis b surface antigen at the pre-study (screening) visit
boolean
C0149709 (UMLS CUI [1])
Major surgery | Blood Donation Amount | Blood Loss Amount | Study Subject Participation Status | Research study
Item
has had major surgery, donated or lost 1 unit of blood (approximately 500 ml) or participated in another investigational study within 4 weeks prior to the prestudy (screening) visit.
boolean
C0679637 (UMLS CUI [1])
C0005794 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C3163616 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C2348568 (UMLS CUI [4])
C0681814 (UMLS CUI [5])
NS5A Inhibitor
Item
previous treatments (s) with nonstructural protein 5a (ns5a) inhibitors
boolean
C3883357 (UMLS CUI [1])
Protease Inhibitors Investigational Recent
Item
<4 weeks since administration of any experimental protease inhibitor
boolean
C0033607 (UMLS CUI [1,1])
C1517586 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
Exposure to Interferon-alpha | Exposure to Ribavirin
Item
previous exposure to interferon-alpha and/or ribavirin within 3 month prior to the first dose of elbasvir in the study
boolean
C0332157 (UMLS CUI [1,1])
C0002199 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0035525 (UMLS CUI [2,2])
Liver disease Advanced | Decompensated liver disease
Item
clinical or laboratory evidence of advanced or decompensated liver disease
boolean
C0023895 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C4075847 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video